independent Janoshik report on selected lots For research purposes only
The information provided is meant for a general audience
[3] The GLP-1 and GIP arms deliver the incretin effects now familiar from drugs like semaglutide and tirzepatide appetite suppression, slowed gastric emptying, and improved glucose handling
Clinical studies Despite their thriving role in the treatment of obesity 214 , only seven studies investigated the effects of GLP-1RAs in eating disorders (Table 6), including some on their psychopathology in comorbid obesity 215,216,217 and others specifically in binge-eating disorder (BED) 217,218,219,220 , and we could not find any ongoing trial in this area
Bning Journal: Molecular therapy : the journal of the American Society of Gene Therapy Journal ranking: Q1 Key takeaways: Tropism-modified AAV vectors with novel receptors significantly improve cutaneous gene therapy by increasing cell entry efficiency and targeting v8 integrin, overcoming safety concerns.